Dutasteride and tamsulosin hydrochloride (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Dutasteride and tamsulosin hydrochloride drug offered from Actavis Pharma, Inc.. This 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Dutasteride and tamsulosin hydrochloride |
| SUBSTANCE NAME: | DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-04-13 |
| END MARKETING DATE: | 0000-00-00 |
Dutasteride and tamsulosin hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dutasteride and tamsulosin hydrochloride from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; .4(mg/1; mg/1) |
| START MARKETING DATE: | 2016-04-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3771_8bfb1a2f-0edb-4486-b5df-363db1583804 |
| PRODUCT NDC: | 0591-3771 |
| APPLICATION NUMBER: | ANDA202975 |
Other DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
